Opportunity ID: 340865

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-22-MRP-IA
Funding Opportunity Title: DoD Melanoma, Idea Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 13
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jun 01, 2022
Last Updated Date: Oct 03, 2022
Original Closing Date for Applications: Oct 05, 2022
Current Closing Date for Applications: Oct 05, 2022
Archive Date: Nov 04, 2022
Estimated Total Program Funding: $10,400,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

The FY22 MRP Idea Award supports innovative, untested, exploratory, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods that are responsive to the FY22 MRP Challenge Statement and address at least one of the FY22 MRP Focus Areas in Section II.A.1. The advancement of knowledge in melanoma research, patient care, and/or treatment options in the Military Health System is critical to active-duty Service Members, Veterans, other military beneficiaries, and the American public.

The purpose of the Idea Award is to generate novel research avenues for investigation; therefore, novelty and innovation should be key aspects of the proposed research. Research supported by the Idea Award must introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. The proposed project can be exploratory, hypothesis-driven or hypothesis-generating research but must be based on a strong scientific rationale and a well-developed study design and plan of analysis.

The Idea Award is not intended to expand or extend previously published findings or continue an established line of research. Incremental advances, the next logical step, or merely switching the object or method of inquiry from one cancer to another cancer is not considered innovative.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Version History

Version Modification Description Updated Date
USAMRAA and CDMRP understand that the effects of Hurricane Ian may be preventing some from submitting their applications. Therefore a 5 day grace period (until 10 October 2022 at 11:59pm ET) is being added only for those affected by the storm (i.e., applicants whose institution is within a FEMA declared disaster area). Please also note, that if you submit an application during the grace period, then you must also submit an appeal to the eBRAP help desk to explain how you were affected by the storm. If you do not submit an appeal with your grace period application, then your application will not be accepted. If you submit an application during the grace period and were not affected by Hurricane Ian, then your application will not be accepted. Oct 03, 2022
Jun 01, 2022

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-22-MRP-IA
Funding Opportunity Title: DoD Melanoma, Idea Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 13
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jun 01, 2022
Last Updated Date: Oct 03, 2022
Original Closing Date for Applications: Oct 05, 2022
Current Closing Date for Applications: Oct 05, 2022
Archive Date: Nov 04, 2022
Estimated Total Program Funding: $10,400,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

The FY22 MRP Idea Award supports innovative, untested, exploratory, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods that are responsive to the FY22 MRP Challenge Statement and address at least one of the FY22 MRP Focus Areas in Section II.A.1. The advancement of knowledge in melanoma research, patient care, and/or treatment options in the Military Health System is critical to active-duty Service Members, Veterans, other military beneficiaries, and the American public.

The purpose of the Idea Award is to generate novel research avenues for investigation; therefore, novelty and innovation should be key aspects of the proposed research. Research supported by the Idea Award must introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. The proposed project can be exploratory, hypothesis-driven or hypothesis-generating research but must be based on a strong scientific rationale and a well-developed study design and plan of analysis.

The Idea Award is not intended to expand or extend previously published findings or continue an established line of research. Incremental advances, the next logical step, or merely switching the object or method of inquiry from one cancer to another cancer is not considered innovative.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-22-MRP-IA
Funding Opportunity Title: DoD Melanoma, Idea Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 13
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 01, 2022
Last Updated Date: Jun 01, 2022
Original Closing Date for Applications:
Current Closing Date for Applications: Oct 05, 2022
Archive Date: Nov 04, 2022
Estimated Total Program Funding: $10,400,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

The FY22 MRP Idea Award supports innovative, untested, exploratory, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods that are responsive to the FY22 MRP Challenge Statement and address at least one of the FY22 MRP Focus Areas in Section II.A.1. The advancement of knowledge in melanoma research, patient care, and/or treatment options in the Military Health System is critical to active-duty Service Members, Veterans, other military beneficiaries, and the American public.

The purpose of the Idea Award is to generate novel research avenues for investigation; therefore, novelty and innovation should be key aspects of the proposed research. Research supported by the Idea Award must introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. The proposed project can be exploratory, hypothesis-driven or hypothesis-generating research but must be based on a strong scientific rationale and a well-developed study design and plan of analysis.

The Idea Award is not intended to expand or extend previously published findings or continue an established line of research. Incremental advances, the next logical step, or merely switching the object or method of inquiry from one cancer to another cancer is not considered innovative.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Folder 340865 Full Announcement-FY22 MRP IA -> W81XWH-22-MRP-IA-GG.pdf

Packages

Agency Contact Information: CDMRP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Email: help@eBRAP.org
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00274747 Jun 01, 2022 Oct 05, 2022 View

Package 1

Mandatory forms

340865 RR_SF424_5_0-5.0.pdf

340865 AttachmentForm_1_2-1.2.pdf

340865 RR_PersonalData_1_2-1.2.pdf

340865 RR_KeyPersonExpanded_4_0-4.0.pdf

340865 RR_Budget_3_0-3.0.pdf

340865 PerformanceSite_4_0-4.0.pdf

Optional forms

340865 RR_SubawardBudget30_3_0-3.0.pdf

2025-07-13T07:58:23-05:00

Share This Post, Choose Your Platform!

About the Author: